Structure of yellow fever virus envelope protein domain III

Virology

Volumn 394, Issue 1, 2009, Pages 12-18

  Volk, David E ^a   May, Fiona J ^b   Gandham, Sai H A ^a   Anderson, Anjenique ^b   Von Lindern, Jana J ^b   Beasley, David W C ^a,b   Barrett, Alan D T ^a,b   Gorenstein, David G ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Envelope protein domain III; Flavivirus; Neutralization site; Yellow fever virus

Indexed keywords

AMINO ACID; METHIONINE; VALINE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; YELLOW FEVER FLAVIVIRUS;

AMINO ACID SEQUENCE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, TERTIARY; RNA, VIRAL; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS; YELLOW FEVER VIRUS;

FLAVIVIRUS; YELLOW FEVER VIRUS;

EID: 70350128768     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.09.001     Document Type: Article

References (38)

1. Beasley D.W., and Barrett A.D. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J. Virol. 76 24 (2002) 13097-13100
2. Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham, T.E., III, Ros, W.S., Simmerling, C.L., Darden, T.A., Merz, K.M., Standon, R.V., Cheng, A.L., Vincent, J.J., Crowly, M., Tsui, V., Radmer, R.J., Duan, Y., Pitera, J., Massova, I., Seibel, G.L., Singh, U.C., Weiner, P.K., Kollman, P.A. 1999. AMBER6, University of California, San Francisco.
3. Cecilia, D., Gould, E.A., 1991. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 181, 70-77.
4. Chu J.J., Rajamanonmani R., Li J., Bhuvanakantham R., Lescar J., and Ng M.L. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J. Gen. Virol. 86 Pt 2 (2005) 405-412
5. Crill W.D., and Roehrig J.T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75 16 (2001) 7769-7773
6. Ferrin T.E., Huang C.C., Jarvis L.E., and Langridge R. The MIDAS display system. J. Mol. Graph. 6 1 (1988) 13-27
7. Goncalvez A.P., Chien C.H., Tubthong K., Gorshkova I., Roll C., Donau O., Schuck P., Yoksan S., Wang S.D., Purcell R.H., and Lai C.J. Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo. J. Virol. 82 14 (2008) 7009-7021
8. Gromowski G.D., and Barrett A.D.T. Characterization of an antigenic site that contains a dominant, type-specific, neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 366 (2007) 349-360
9. Heinz F.X., and Allison S.L. Flavivirus structure and membrane fusion. Adv. Virus Res. 59 (2003) 63-97
10. Hiramatsu K., Tadano M., Men R., and Lai C.J. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology 224 2 (1996) 437-445
11. Holzmann, H., Heinz, F.X., Mandl, C.W., Guirakhoo, F., Kunz, C., 1990. A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J. Virol. 64, 5156-5159.
12. Holzmann H., Stiasny K., Ecker M., Kunz C., and Heinz F.X. Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J. Gen. Virol. 78 Pt 1 (1997) 31-37
13. Hung J.J., Hsieh M.T., Young M.J., Kao C.L., King C.C., and Chang W. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J. Virol. 78 1 (2004) 378-388
14. Kanai R., Kar K., Anthony K., Gould L.H., Ledizet M., Fikrig E., Marasco W.A., Koski R.A., and Modis Y. Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J. Virol. 80 22 (2006) 11000-11008
15. Koradi, R., Billeter, M., and Wuthrich, K., (1996). MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14(1), 51-5, 29-32.
16. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., and Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108 5 (2002) 717-725
17. Lin C.W., and Wu S.C. A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J. Virol. 77 4 (2003) 2600-2606
18. Mandl C.W., Guirakhoo F., Holzmann H., Heinz F.X., and Kunz C. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J. Virol. 63 2 (1989) 564-571
19. Modis Y., Ogata S., Clements D., and Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 100 12 (2003) 6986-6991
20. Modis Y., Ogata S., Clements D., and Harrison S.C. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 79 2 (2005) 1223-1231
21. Mukherjee M., Dutta K., White M.A., Cowburn D., and Fox R.O. NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition. Protein Sci. 15 6 (2006) 1342-1355
22. Mukhopadhyay S., Kim B.S., Chipman P.R., Rossmann M.G., and Kuhn R.J. Structure of West Nile virus. Science 302 5643 (2003) 248
23. Nayak V., Dessau M., Kucera K., Anthony K., Ledizet M., and Modis Y. Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J. Virol. 83 9 (2009) 4338-4344
24. Nybakken G.E., Oliphant T., Johnson S., Burke S., Diamond M.S., and Fremont D.H. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437 7059 (2005) 764-769
25. Nybakken G.E., Nelson C.A., Chen B.R., Diamond M.S., and Fremont D.H. Crystal structure of the West Nile virus envelope glycoprotein. J. Virol. 80 23 (2006) 11467-11474
26. Rey F.A., Heinz F.X., Mandl C., Kunz C., and Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375 6529 (1995) 291-298
27. Roehrig J.T., Bolin R.A., and Kelly R.G. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246 2 (1988) 317-328
28. Ryman K.D., Ledger T.N., Campbell G.A., Watowich S.J., and Barrett A.D. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Virology 244 1 (1998) 59-65
29. Sánchez M.D., Pierson T.C., McAllister D., Hanna S.L., Puffer B.A., Valentine L.E., Murtadha M.M., Hoxie J.A., and Doms R.W. Characterization of neutralizing antibodies to West Nile virus. Virology 336 1 (2005) 70-82
30. Sukupolvi-Petty S., Austin S.K., Purtha W.E., Oliphant T., Nybakken G.E., Schlesinger J.J., Roehrig J.T., Gromowski G.D., Barrett A.D., Fremont D.H., and Diamond M.S. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognized adjacent epitopes. J. Virol. 81 (2007) 12816-12826
31. Volk D.E., Beasley D.W., Kallick D.A., Holbrook M.R., Barrett A.D., and Gorenstein D.G. Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J. Biol. Chem. 279 37 (2004) 38755-38761
32. Volk D.E., Chavez L., Beasley D.W., Barrett A.D., Holbrook M.R., and Gorenstein D.G. Structure of the envelope protein domain III of Omsk hemorrhagic fever virus. Virology 351 1 (2006) 188-195
33. Volk D.E., Gandham S.H.A., May F.J., Anderson A., Barrett A.D., and Gorenstein D.G. NMR assignments of the yellow fever virus envelope protein domain III. Biomol. NMR Assign. 1 (2007) 49-50
34. Volk D.E., Lee Y.C., Li X., Thiviyanathan V., Gromowski G.D., Li L., Lamb A.R., Beasley D.W., Barrett A.D., and Gorenstein D.G. Solution structure of the envelope protein domain III of dengue-4 virus. Virology 364 1 (2007) 147-154
35. Wu S.C., and Lin C.W. Neutralizing peptide ligands selected from phage-displayed libraries mimic the conformational epitope on domain III of the Japanese encephalitis virus envelope protein. Virus Res. 76 1 (2001) 59-69
36. Wu S.C., Lian W.C., Hsu L.C., and Liau M.Y. Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence. Virus Res. 51 2 (1997) 173-181
37. Wu K.P., Wu C.W., Tsao Y.P., Kuo T.W., Lou Y.C., Lin C.W., Wu S.C., and Cheng J.W. Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J. Biol. Chem. 278 46 (2003) 46007-46013
38. Wu S.C., Lin Y.J., Chou J.W., and Lin C.W. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization. Vaccine 23 2 (2004) 163-171